Brompheniramine chemical structure
Find information on thousands of medical conditions and prescription drugs.

Brompheniramine

Brompheniramine is an antihistaminergic medication of the propylamine class. It is commonly available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine. more...

Home
Diseases
Medicines
A
B
Baciim
Bacitracin
Baclofen
Bactrim
Bactroban
Barbexaclone
Barbital
Baros
Basiliximab
Baycol
Beclamide
Beclometasone
Beclovent
Beconase
Beldin
Benadryl
Benazepril
Bendroflumethiazide
Benserazide
Bentiromide
Benylin
Benzaclin
Benzalkonium chloride
Benzocaine
Benzonatate
Betacarotene
Betadine
Betahistine
Betamethasone
Betaxolol
Bextra
Biaxin
Bibrocathol
Bicalutamide
Bicillin
Biclotymol
Biotin
Bisoprolol
Bleomycin
Blocadren
Boldenone
Boniva
Bontril
Bosentan
Bravelle
Brethaire
Brevibloc
Brevicon
Bricanyl
Bromazepam
Bromelain
Bromhexine
Bromocriptine
Brompheniramine
Bronkodyl
Bronopol
BSS
Bucet
Budesonide
Bumetanide
Bupivacaine
Buprenex
Buprenorphine
Buserelin
Buspar
Buspirone
Busulfan
Butalbital
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Brompheniramine works by acting as an antagonist of the H1 receptors. It also functions as a moderately effective anticholingeric agent, likely an antimuscarinic agent similar to other common antihistamines such as diphenhydramine. Its effects on the cholinergic system may include side-effects such as drowsiness, sedation, dry mouth, dry throat, blurred vision, and increased heart rate.


Read more at Wikipedia.org


[List your site here Free!]


Toxicity of Cough and Cold Medications in Children
From American Family Physician, 3/15/02 by Grace Brooke Huffman

Upper respiratory infections are common in children and are often treated with over-the-counter (OTC) cough and cold preparations. However, these medications have not proved to be efficacious in relieving children's symptoms. Gunn and colleagues reviewed several case reports of toxicity caused by these preparations.

Cough and cold preparations have been shown to decrease symptoms in adolescents and adults, but a comparison of OTC preparations and placebo in younger children showed no significant difference in reducing cough. The side effects of these medications are potentially harmful. One study of 249,038 exposures to OTC cough and cold preparations in children younger than six years cited 72 major adverse effects and four deaths.

Several years ago, the American Academy of Pediatrics recommended that physicians educate parents and caregivers about the risks of using medicines containing codeine and dextromethorphan in children. In addition, the U.S. Food and Drug Administration has recommended that all phenylpropanolamine (PPA) preparations be removed from the market.

Pseudoephedrine is a sympathomimetic agent that stimulates alpha-adrenergic receptors on smooth muscle and can reduce nasal congestion. Toxic effects include hypertension, tachycardia, and central nervous system (CNS) stimulation (presenting as agitation, insomnia, psychosis, and/or seizures). Cerebral hemorrhage and stroke are other possible toxic effects. Dysrhythmias and myocardial infarction have also been reported. PPA toxicity can present with similar toxic effects, except that bradycardia might occur in place of the tachycardia that occurs with the use of pseudoephedrine.

Chlorpheniramine and brompheniramine are antihistamines used in many cough and cold preparations, although histamine does not seem to be a factor in cold symptoms in children. These agents can cause CNS depression and other anticholinergic symptoms. Other possible symptoms of toxicity include tachycardia, blurred vision, agitation, hyperactivity, and seizures. Torsades de pointes has also occurred. Dextromethorphan has been known to cause lethargy, stupor, hyperexcitability, abnormal limb movements, and coma.

Toxicity may occur for several reasons: unclear labeling (in one case study, the parents thought they were giving their child Tylenol, not realizing that the preparation was actually Tylenol Cold medicine), dosing errors, and use of adult formulations rather than those appropriate for children.

The authors conclude that OTC cough and cold medications are not effective in children and are associated with many potential toxicities. They recommend that, if a parent insists on giving one of these medications to a child, the physician should negotiate discontinuation within two days if the child fails to improve.

COPYRIGHT 2002 American Academy of Family Physicians
COPYRIGHT 2002 Gale Group

Return to Brompheniramine
Home Contact Resources Exchange Links ebay